Sera Prognostics, Inc. (SERA)
2.04
+0.01
(+0.49%)
USD |
NASDAQ |
Oct 16, 13:39
Sera Prognostics SG&A Expense (TTM) : 24.17M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 24.17M |
| March 31, 2026 | 23.64M |
| December 31, 2025 | 23.25M |
| September 30, 2025 | 23.82M |
| June 30, 2025 | 23.52M |
| March 31, 2025 | 22.42M |
| December 31, 2024 | 21.90M |
| September 30, 2024 | 20.59M |
| June 30, 2024 | 19.86M |
| March 31, 2024 | 22.82M |
| December 31, 2023 | 24.69M |
| September 30, 2023 | 26.66M |
| June 30, 2023 | 29.06M |
| Date | Value |
|---|---|
| March 31, 2023 | 29.75M |
| December 31, 2022 | 31.48M |
| September 30, 2022 | 34.03M |
| June 30, 2022 | 33.72M |
| March 31, 2022 | 29.78M |
| December 31, 2021 | 24.42M |
| September 30, 2021 | 14.94M |
| June 30, 2021 | 10.96M |
| March 31, 2021 | 8.928M |
| December 31, 2020 | 7.538M |
| September 30, 2020 | 7.538M |
| June 30, 2020 | 4.78M |
| March 31, 2020 | 2.247M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Myriad Genetics, Inc. | 539.90M |
| BioRestorative Therapies, Inc. | 5.181M |
| CareDx, Inc. | 247.69M |
| Natera, Inc. | 1.255B |
| Exagen, Inc. | 48.45M |